<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Mccarthy Karlsen | Activity</title>
	<link>https://www.catswannabecats.com/members/judocard3/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/judocard3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mccarthy Karlsen.</description>
	<lastBuildDate>Wed, 08 Jul 2026 13:16:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b20f90bd9a8da2ece21b06a3867d2cd7</guid>
				<title>Mccarthy Karlsen posted an update: Despite the advances in screening protocols and treatment [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9305/</link>
				<pubDate>Sat, 31 May 2025 22:28:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>Despite the advances in screening protocols and treatment options, hepatocellular carcinoma (HCC) is still considered to be the most lethal malignancy in patients with liver cirrhosis. Moreover, the survival outcomes after failure of first-line therapy for unresectable HCC is still poor with limited therapeutic options. One of these options is&hellip;<span class="activity-read-more" id="activity-read-more-9305"><a href="https://www.catswannabecats.com/activity/p/9305/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">85dd0a3bb1f6d59ee2e75ff5ba053ae4</guid>
				<title>Mccarthy Karlsen became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/9160/</link>
				<pubDate>Sat, 31 May 2025 22:15:37 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>